PERSON: Scott Gottlieb

Pfizer, Illumina, Aetion, and Tempus

Board Member

Scott Gottlieb, MD, is a resident fellow at the American Enterprise Institute. From 2017 to 2019 he served as the 23rd commissioner of the Food and Drug Administration. Dr. Gottlieb is also a special partner with the venture capital firm New Enterprise Associates and serves on the boards of Pfizer, Illumina, Aetion, and Tempus.

In addition to his frequent testimonies before Congress, Dr. Gottlieb is often published and interviewed by the media. He is a regular guest on Face The Nation and a contributor to CNBC, and his commentary and articles have appeared in Health Affairs, The Wall Street Journal, The Washington Post, and The New York Times, among other outlets.

[Https://www.uncontrolledspread.com/]